Clinical Trials Browser

OTHER × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Sitagliptin Phosphate × Clear all

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01720264 2019-01-08

Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

Phase 2 Completed

15 enrolled 11 charts

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00862719 2016-10-07

Sitagliptin Umbilical Cord Blood Transplant Study

Phase 2 Completed

29 enrolled 15 charts

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Lymphoma, Non-Hodgkin, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD

Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

Sitagliptin Umbilical Cord Blood Transplant Study